The role of hepatocyte growth factor activator inhibitor-2 in response to cisplatin treatment in oral squamous cell carcinoma
碩士 === 國立陽明大學 === 口腔生物研究所 === 102 === Hepatocyte growth factor activator inhibitor type 2 (HAI-2) is one of the Kunitz-type serine protease inhibitor. The function of HAI-2 is to inactivate the serine protease and the downstream signaling transduction. The previous study found that the HAI-2 express...
Main Authors: | Shang-Yi Chiu, 邱尚儀 |
---|---|
Other Authors: | Kan-Tai Hsia |
Format: | Others |
Language: | zh-TW |
Published: |
2014
|
Online Access: | http://ndltd.ncl.edu.tw/handle/34719554171047087787 |
Similar Items
-
The role of HAI-1 in oral squamous cell carcinoma under cisplatin treatment
by: Jhih-Cheng Jiang, et al.
Published: (2013) -
MECHANISM OF APOPTOSIS INHIBITION TO SQUAMOUS CELL CARCINOMA OF ORAL CANCER IN CISPLATIN TREATMENT
by: R Marjono Dwi Wibowo, et al.
Published: (2017-08-01) -
Osteopontin Involves Cisplatin Resistance and Poor Prognosis in Oral Squamous Cell Carcinoma
by: Sheng-Dean Luo, et al.
Published: (2015-01-01) -
Synergetic Effects of PARP Inhibitor AZD2281 and Cisplatin in Oral Squamous Cell Carcinoma in Vitro and in Vivo
by: Masaaki Yasukawa, et al.
Published: (2016-02-01) -
Efficacy of tyrosine kinase inhibitors in combination chemotherapy with cisplatin and 5-fluorouracil oral Squamous cell carcinoma in vitro
by: Knierim, Marie Luise
Published: (2019)